Novel Osteoporosis Medications – Insights from High BMD Disorders
Learn how an increased understanding of the pathophysiology of these disorder gives insight into the development of new targeted osteoporosis therapies.
You will learn:
• Artefactual and acquired causes of high BMD
• Inherited causes of generalised high BMD
• High BMD disorders associated with decreased bone resorption and increased bone deposition
• How increased understanding of the pathophysiology of these disorders gives insight into the development of new targeted osteoporosis therapies.
Talk from NOFSA 2021 Virtual Congress Held on 5-7 August 2021
ATTENTIONKindly note that if you attended the live webinar, you have already received 1 CPD point and will not be permitted to receive additional points for the report. Should this occur, the HPCSA will only record the 1 CPD point from the live webinar, invalidating any additional CPD points from the report.
Please note deNovo Medica ensures uploading of your CPD points to the HPCSA: please don’t upload these yourself.
To access this module, please register or login: